SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page89101112131415Next Page
2026-07-22WINT8-KWindtree Therapeutics Divests Cardiovascular Drug Candidates to Seismic Pharmaceutical OperationsHIGH
On December 16, 2025, Windtree Therapeutics, Inc. entered into an Asset Purchase Agreement to sell its cardiovascular drug candidates to Seismic Pharmaceutical Operations, LLC (SPO). Under the agreement, Windtree received an initial cash payment of $150,000 and is entitled to 20% of any future milestone payments, royal...
BiotechnologyPartnership / Licensing
2026-07-22COEP8-KZ Squared Inc. Terminates $300M ATM Program and $50M Equity Forward Purchase AgreementMEDIUM
On July 17, 2026, Z Squared Inc. (Nasdaq: ZSQR) issued written notice to terminate two major equity financing arrangements: a $300 million At-The-Market (ATM) Sales Agreement with Roth Capital Partners and a $50 million Committed Equity Forward Purchase Agreement with Translucent Matter Inc. The ATM termination is effe...
Micro CapBiotechnologyEquity Offering
Previous Page89101112131415Next Page